NEW
Stock Screener with Intrinsic Value
Repligen Corporation (RGEN)
Last Price$159.9(3.8%)
Market Cap$8,954.8M
RGEN Rating
Crunching data... Almost there!
RGEN Intrinsic Value
RGEN Share Price History
1W (3.7%)
1M 6.7%
6M (1.4%)
YTD (10.8%)
1Y (18.5%)
3Y (19.4%)
5Y 56.1%
10Y 594.8%
RGEN Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!
RGEN Stock Financials
RGEN Income Statement Metrics
Crunching data... Almost there!
RGEN Cash Flow Statement Metrics
Crunching data... Almost there!
RGEN Income Statement Overview
Crunching data... Almost there!
RGEN Balance Sheet Overview
Crunching data... Almost there!
RGEN Stock Ratios
Crunching data... Almost there!
RGEN Earnings Surprises
Crunching data... Almost there!
RGEN Dividends
RGEN Dividend Yield
Crunching data... Almost there!
RGEN Dividend Per Share
Crunching data... Almost there!
Competing with RGEN
Overview
Ratings
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
FAQ
What is Repligen Corporation (RGEN) stock rating?
As of today, Repligen Corporation has a stock rating of 6 (out of 10), which is considered Good.
is Repligen Corporation (RGEN) a good stock to buy?
As of today, Repligen Corporation has a Good stock rating, which is 80.8% overvalued. According to Value Sense backtesting, stocks with similar profile tend to underperform the market by 4.6%.